The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden
Abstract Vaccination against SARS-CoV-2 started in Region Stockholm, Sweden in December 2020 with those in long-term care facilities or receiving home care vaccinated first followed by those aged over 80 years. In this population-based, retrospective cohort study, we performed a Poisson regression to model the expected incidence of infections and deaths which we compared to the observed incidence and compared this to an unvaccinated control group of those aged 18-79 years. The aim of this study was to measure the early impact of the vaccination programme in Region Stockholm.Infections and deaths reduced substantially amongst the first two groups targeted for SARS-CoV-2 vaccination with an estimated total 3112 infections prevented, and 854 deaths prevented in these two groups from 4 weeks after the introduction of vaccination through to 2nd May 2021..
Medienart: |
Preprint |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
bioRxiv.org - (2022) vom: 25. Mai Zur Gesamtaufnahme - year:2022 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Isitt, Catherine [VerfasserIn] |
---|
Links: |
---|
doi: |
10.1101/2021.09.02.21263046 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
XBI032533381 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | XBI032533381 | ||
003 | DE-627 | ||
005 | 20230429093437.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210908s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1101/2021.09.02.21263046 |2 doi | |
035 | |a (DE-627)XBI032533381 | ||
035 | |a (biorXiv)10.1101/2021.09.02.21263046 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 570 |q DE-84 | |
100 | 1 | |a Isitt, Catherine |e verfasserin |4 aut | |
245 | 1 | 0 | |a The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Vaccination against SARS-CoV-2 started in Region Stockholm, Sweden in December 2020 with those in long-term care facilities or receiving home care vaccinated first followed by those aged over 80 years. In this population-based, retrospective cohort study, we performed a Poisson regression to model the expected incidence of infections and deaths which we compared to the observed incidence and compared this to an unvaccinated control group of those aged 18-79 years. The aim of this study was to measure the early impact of the vaccination programme in Region Stockholm.Infections and deaths reduced substantially amongst the first two groups targeted for SARS-CoV-2 vaccination with an estimated total 3112 infections prevented, and 854 deaths prevented in these two groups from 4 weeks after the introduction of vaccination through to 2nd May 2021. | ||
700 | 1 | |a Sjöholm, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Hergens, Maria-Pia |e verfasserin |4 aut | |
700 | 1 | |a Granath, Fredrik |e verfasserin |4 aut | |
700 | 1 | |a Nauclér, Pontus |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2022) vom: 25. Mai |
773 | 1 | 8 | |g year:2022 |g day:25 |g month:05 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.vaccine.2022.03.061 |z lizenzpflichtig |3 Volltext |
856 | 4 | 0 | |u http://dx.doi.org/10.1101/2021.09.02.21263046 |z kostenfrei |3 Volltext |
912 | |a GBV_XBI | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |j 2022 |b 25 |c 05 | ||
953 | |2 045F |a 570 |